France· FR:62744949
PREXATE 12,5 mg/ 0,31 ml,solution injectable en seringue préremplie
A medicinal product containing méthotrexate, registered in France by ALFASIGMA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTHOTREXATE
- Manufacturer
- ALFASIGMA FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301202311 seringue(s) préremplie(s) en verre de 0,31 ml avec 1 tampon alcooliséEUR 10.96
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Méthotrexate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFOXIEMOeasyMed s.r.o., Praha 10
- United KingdomEbetrex 10mg/1ml solution for injection pre-filled syringesSandoz Ltd
- SwitzerlandJylamvo
- NetherlandsBasitrin 10 mg=0,267 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlBasic Pharma Manufacturing B.V.
- BelgiumBasitrin 10 mgBasic Pharma Manufacturing
- SpainBERTANEL 10 mg/1 ml SOLUCION INYECTABLE EN JERINGA PRECARGADAEbewe Pharma Ges.M.B.H. Nfg.Kg
- SwedenEbetrex 2,5 mg TablettEBEWE Pharma Ges.m.b.H.Nfg.KG
- FinlandEbetrexEbewe Pharma Ges.m.b.H. Nfg.KG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebetrexat, Methofill
- Belgium · Basitrin, Emthexate
- Bulgaria · Ebetrexat, Инжексат
- Cyprus · Injexate, Methotrexate Accord
- Czechia · Foxiemo, Injexate
- Germany · Lantarel, Lantarel Fs
- Denmark · Ebetrex, Emthexate
- Estonia · Ebetrex, Metex
- Spain · Bertanel, Imeth
- Finland · Ebetrex, Injexate
- United Kingdom (Northern Ireland) · Ebetrex, Injexate
- Greece · Methobion, Methotrexate Pfizer
- Croatia · Ebetrexat, Methofill
- Hungary · Ebetrexat, Methofill
- Ireland · Methofill, Methotrexate Abcur
- Iceland · Jylamvo, Methotrexat Ebewe
- Italy · Afslamet, Immutrex
- Liechtenstein · Jylamvo, Nordimet
- Lithuania · Ebetrexat, Metex
- Luxembourg · Emthexate, Emthexate Teva Pharma
- Latvia · Ebetrex, Metex
- Malta · Methotrexate Aspire Pharma (Malta)
- Netherlands · Basitrin, Ebetrex
- Norway · Ebetrex, Jylamvo
- Poland · Ebetrexat, Metex
- Portugal · Fauldexato, Ledertrexato
- Romania · Methotrexat Ebewe, Metorthrit
- Sweden · Ebetrex, Injexate
- Slovenia · Methofill, Metoject
- Slovakia · Foxiemo, Injexate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba334360-8f3e-40e3-aae4-61c62e6f9e42 GET /v1/drugs/ba334360-8f3e-40e3-aae4-61c62e6f9e42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62744949",
"date_amm": "2018-01-15",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉTHOTREXATE",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about méthotrexate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.